唯尔本作为一种新型的生物免疫调节剂近 2 a来在治疗小儿哮喘中取得一定疗效 ,现总结如下。1　临床资料1.1　性别与年龄 :6 8例中男 5 2例 ,女 16例 ,男女之比 3.2 5 :1,年龄自 6个月至 7岁 ,其中 1岁以内 15例 ,1～ 2岁 2 4例 ,2～ 3岁 15例 ,4～ 5岁 10例 ,6～ 7岁 4例。1.2 Wurben as a new biological immune modulator nearly 2 a in the treatment of pediatric asthma achieved some effect, are summarized as follows. 1 Clinical data 1.1 Sex and age: 68 cases of male 52 cases, 16 females, male to female ratio of 3.2 5: 1, age from 6 months to 7 years, of which 15 were within 1 year old, 1 to 2 years old 2 4 cases, 2 to 3 years in 15 cases, 4 to 5 years in 10 cases, 6 to 7 years in 4 cases. 1.2